Establishing a Unified COVID-19 “Immunome”: Integrating Coronavirus Pathogenesis and Host Immunopathology

sponsorship: We acknowledge internal funding by KU Leuven (Belgium), UZ Leuven (Belgium) and VIB (Belgium) for this study, as well as the massive effort of all patients, researchers (PhDs/postdocs/technicians), clinicians and nurses involved in COntAGIous clinical-trial consortium (NCT04327570), currently aiming to establish a COVID-19 immunome. EW is supported by Stichting tegen Kanker (Mandate for basic & clinical oncology research). JG holds a postdoctoral research fellowship granted by the University Hospitals Leuven. AG is supported by Research Foundation Flanders (FWO) (G0B4620N; EOS grant: 30837538), KU Leuven (C14/19/098; POR/16/040) and Kom op Tegen Kanker (KOTK/2018/11509/1). (KU Leuven (Belgium), UZ Leuven (Belgium), VIB (Belgium), Stichting tegen Kanker (Mandate for basic & clinical oncology research), University Hospitals Leuven, Research Foundation Flanders (FWO)|G0B4620N, Research Foundation Flanders (FWO) (EOS grant)|30837538, KU Leuven|C14/19/098, KU Leuven|POR/16/040, Kom op Tegen Kanker|KOTK/2018/11509/1)